Brinzolamide

Overview

Brinzolamide (AL-4862) is a selective carbonic anhydrase II inhibitor with an IC 50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide can be used in glaucoma disease research .

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Others | Products > Signaling Pathways > Carbonic Anhydrase

Product Information

• Catalog No.: HY-B0588
• CAS No.: 138890-62-7
• Molecular Formula: C12H21N3O5S3
• Molecular Weight: 383.51
• Purity: 99.91%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.75 mg/mL (7.17 mM); Clear solution
• Availability: In-stock

Source

Original product source